![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 18, 15801-15806, May 3, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, October 22, 2001, and in revised form, February 6, 2002
Secretory granules of neuroendocrine cells are
inositol 1,4,5-trisphosphate (InsP3)-sensitive
Ca2+ stores in which the Ca2+ storage protein,
chromogranin A (CGA), couples with InsP3-gated Ca2+ channels (InsP3R) located in the
granule membrane. The functional aspect of this coupling has been
investigated via release studies and planar lipid bilayer experiments
in the presence and absence of CGA. CGA drastically increased the
release activity of the InsP3R by increasing the channel
open probability by 9-fold and the mean open time by 12-fold. Our
results show that CGA-coupled InsP3Rs are more sensitive to
activation than uncoupled receptors. This modulation of
InsP3R channel activity by CGA appears to be an essential
component in the control of intracellular Ca2+
concentration by secretory granules and may regulate the rate of
vesicle fusion and exocytosis.
CGA1 is a member of the
granin protein family and is stored in high concentrations in the large
dense core secretory granules of most endocrine and neuroendocrine
cells as well as in many nerve cells in the periphery and brain (1, 2).
CGA, the first member of the granin family to be discovered (3-5), has a wide variety of functions, both extracellular and intracellular.
As one of its extracellular functions, CGA acts as a prohormone, a
protein that contains numerous sites for proteolytic processing. Following secretion, extracellular proteases cleave CGA, generating several peptide fragments with biological activity, including pancreastatin (6, 7), vasostatins I and II (8-10), parastatin (11),
catestatin (12), and chromacin (13). In healthy individuals, CGA and
its peptide fragments are present in the circulatory system in low
nanomolar quantities. However, in patients suffering from pheochromocytoma and other neuroendocrine tumors, concentrations are
significantly higher (14). Elevated plasma levels of CGA are associated
with a number of pathological conditions making the protein an ideal
marker not only for neuroendocrine tumors but also for chronic heart
failure and brain disorders such as Parkinson's and Alzheimer's
diseases (15).
Among its intracellular roles, CGA has been shown to interact with ATP,
catecholamines, and Ca2+ (16, 17), to acidify the
intravesicular medium and to sort proteins for the regulated secretory
pathway via a range of protein-protein interactions (15). These sorting
functions include aggregation with chromogranin B, complexing
with dopamine In recent years, secretory granules of neuroendocrine cells
have been identified as inositol (1,4,5)-trisphosphate
(InsP3)-sensitive Ca2+ stores (18-20). In the
granules CGA forms a tetramer and appears to bind four molecules of the
intraluminal loop of the InsP3R at the intravesicular pH
5.5 (21-23). In vitro studies show that purified
InsP3R interact directly with CGA at this pH and dissociate from it at pH 7.5, a pH encountered when exocytosis occurs (24). Co-transfection of InsP3R and CGA into COS-7 cells followed
by co-immunoprecipitation demonstrates that these two proteins form a
complex in vivo (24).
We have investigated the functional aspect of this coupling via
InsP3-mediated Ca2+ release studies using
InsP3R-reconstituted liposomes in the presence and absence
of CGA. We have further characterized the molecular basis of this
phenomenon at the single channel level using planar lipid bilayer
studies. In the presence of CGA the open probability and mean open time
of the InsP3R channel increases significantly. Hence,
modulation of InsP3R channel activity by CGA appears to be
an essential component in the control of intracellular Ca2+
concentration in secretory granules.
Purification of the InsP3 Receptor
For Flux Studies--
The type I InsP3 receptor was
isolated from bovine cerebella as described previously (25). Briefly,
bovine cerebella were mixed with 3 volumes of buffer I (50 mM Tris-HCl, pH 7.4, 0.32 M sucrose, 1 mM EDTA, 1 mM For Bilayer Experiments--
The type I InsP3
receptor was solubilized in 1% CHAPS and purified from mouse
cerebellum using heparin affinity and concanavalin A-Sepharose column
chromatography as described previously (26). The purified
InsP3R was then incorporated into liposomes by adding 15 µg of purified protein to 1 ml of liposome solution (consisting of
phosphatidylcholine in bilayer buffer), mixing, and then incubating on
ice for 10 min.
Flux Studies
InsP3 Dose Response for
InsP3R--
InsP3R proteoliposomes were formed
as described previously (25). Some of these proteoliposomes had CGA
encapsulated in them, and the remainder was used for control
experiments. Ca2+ efflux from the proteoliposomes was
measured by observing changes in indo-1 fluorescence. Fluorometric
measurements were carried out at 35 °C using a Shimadzu RF-5301 PC
spectrofluorometer equipped with a temperature-controlled cuvette
holder. Fluorescence intensity was measured at the emission wavelength
of 393 nm (excitation of 355 nm) with 10 nm of excitation band slit
width and 10 nm of emission band slit width. For the kinetic analysis
of InsP3-induced Ca2+ release, the data were
acquired every 20 ms after each addition of the indicated
InsP3 concentration to 0.5 ml of the proteoliposome solution. The fluorescent intensities of indo-1 were calibrated to free
Ca2+ concentrations using a Ca2+-EGTA buffering
system (27).
InsP3 dose-dependent Ca2+ release
was also measured by the intensity of indo-1 fluorescence after each
InsP3 addition and was compared with the fluorescence
intensity after the addition of Triton X-100 instead of
InsP3. In these experiments, 10 µM indo-1 was
used, which is a high enough concentration to buffer released Ca2+, thus precluding the possibility of Ca2+
regulation of the InsP3-induced release.
Bilayer Experiments--
Planar lipid bilayers were formed by
painting a solution of phosphatidylethanolamine/phosphatidylserine
(3:1; 30 mg/ml in decane) across a 100 µm aperture in a Teflon sheet
bisecting a Lucite chamber. The hole was pre-painted with
phosphatidylcholine/phosphatidylserine (3:1) prior to membrane
formation. The two compartments are defined as cis
(corresponding to the cytosol) and trans (corresponding to
the lumen of the ER).
The cis (cystolic) compartment consisted
of 250 mM HEPES, Tris, pH 7.35, 0.5 mM EGTA
([Ca2+]free = 200 nM), ATP 0.5 mM, and ruthenium red 2 µM.
The trans (luminal) compartment consisted
of 250 mM HEPES, adjusted to pH 5.5 (as purified
InsP3R was used in these experiments, the pH could be
changed using 70 mM HCl), and 53 mM
Ba(OH)2. Single channel currents were amplified using a
bilayer clamp amplifier (Warner Instruments) and recorded on digital
tape. Data was filtered with an eight-pole Bessel filter to 500 Hz,
digitized to 2 kHz, transferred to a personal computer, and analyzed
using the pClamp 6.0 (Axon Instruments) software package.
InsP3R proteoliposomes were added to the cis
compartment and mixed followed by the addition of 2 µM
InsP3 to the same compartment. Upon InsP3R
activation, single channel activity was recorded. CGA (1 µg) was
added to the trans compartment and mixed. InsP3R single channel activity was recorded. The pH inside the
trans compartment was changed by adding Tris (final
concentration 110 mM) to pH 7.5 (to dissociate CGA from
InsP3R), and InsP3R single channel activity was recorded.
These experiments were repeated (i) in the presence of increasing doses
of InsP3 (over the range of 0.2-2 µM) to the
cis compartment and (ii) at a fixed InsP3
concentration of 2 µM in the presence of increasing free
Ca2+ concentrations (over the range of 0.01-1
µM) to the cis compartment. Both steps i and
ii were carried out in the presence and absence of 1 µg of CGA in the
trans compartment, and InsP3R single channel activity was recorded.
Effect of CGA on InsP3-mediated Ca2+
Release--
The effect of CGA on InsP3 dose response for
type I InsP3R from bovine cerebella was investigated
initially using Ca2+ release studies.
InsP3-induced Ca2+ release from
InsP3R-reconstituted liposomes was monitored both in the
presence and absence of CGA (Fig. 1).
InsP3-induced Ca2+ efflux through the
proteoliposomes (300 µM Ca2+ inside) was
determined by the change of indo-1 fluorescence at 393 nm. The total
amount of Ca2+ in the liposomes was determined by adding
1% Triton X-100, and this was the value set at 100%. Given this
information, the total amount of InsP3-releasable
Ca2+ was estimated to be 60%. When CGA was present inside
the vesicle at pH 5.5, the pH value at which CGA associates with the
InsP3R, InsP3-induced Ca2+ release
was significantly enhanced (see Fig. 1a). A
Kapp value for InsP3 of 0.2 µM was obtained. When the pH was maintained at 7.5, however, the fluorescent changes seen at each InsP3 dose more closely resembled those seen in the absence of CGA at pH 5.5 (Kapp values for InsP3 of 0.8 and
0.9 µM, respectively), further supporting the pH
dependence of the InsP3R/CGA interaction. The presence of
CGA at pH 5.5 markedly increased the apparent affinity of the receptor
for InsP3 when compared with the Ca2+ release
obtained in the absence of CGA. This result complements the effect of
CGA on InsP3 binding to its receptor (25). Even at
InsP3 concentrations lower than those published previously (starting at 0.05 µM) (25), an increase in apparent
affinity for InsP3 was seen (Fig. 1b).
Effect of CGA upon InsP3R Channel Activity--
The
enhancement of Ca2+ release from
InsP3R-reconstituted liposomes as a result of the
pH-dependent interaction of CGA with InsP3R,
illustrates a functional phenomenon associated with this coupling. To
further define the actual mechanism of action, we investigated these
effects at the single channel level using InsP3 R
incorporated into planar lipid bilayers.
Under control conditions, in the absence of luminal CGA and in the
presence of cytosolic free Ca2+ (300 nM) and
InsP3 (2 µM), mouse InsP3R
type I, single channel activity was observed (see Fig.
2a, trace i).
Single channel currents of ~2 pA were seen, and the presence of a pH
gradient between the trans and cis compartments
(pH 5.5:pH 7.35) did not affect channel activity. Two populations of
mean open times were seen with values of 0.864 ± 0.039 and
8.84 ± 0.014 ms (Fig.
3a). The data set is further
expanded (Fig. 3b) to emphasize the complete population of
longer open times. The open probability (Po) was 4.0 ± 1.0% (S.E.) (n = 4).
Less than 1 min after the addition of 1 µg of CGA to the
trans compartment, a dramatic change in channel activity was
observed (Fig. 2a, trace ii). The magnitude of
the single channel current remained unaltered; however, significant
differences were apparent in mean open times and
Po. Two populations of mean open time were evident, as before, but were greatly increased over control values (Fig. 3c). Values of 2.61 ± 0.024 and 103.5 ± 0.003 ms were obtained, illustrating an approximate 3-fold and 12-fold
increase of open time in each respective population. This is displayed
even more clearly when the scale from Fig. 3c is expanded to
focus on the population of longer open times (Fig. 3d).
Furthermore, a large increase in Po over control
levels was seen with a value of 33.0 ± 8.5% (S.E.)
(n = 4).
By changing the pH of the trans compartment to 7.5, a
condition known to cause dissociation of CGA from InsP3R,
channel activity essentially reverted to control levels (Fig.
2a, trace iii). The two populations of mean open
time were reduced to 1.05 ± 0.014 and 7.19 ± 0.013 ms
(n = 4, Fig. 3e, and compare with Fig.
3a), and the Po was reduced to
3.0 ± 1.6% (S.E.), a value close to that seen for the control.
The addition of heparin, an InsP3R-specific antagonist, to
the cis compartment inhibited channel activity completely.
A similar study was carried out using microsomes from mouse cerebellum
to see whether the effects of CGA would still be seen in native tissue
the same as in purified protein. These experiments were
complicated by the fact that HCl was present in the trans compartment, a condition necessary for maintaining the pH at 5.5. Thus
chloride channels present in the microsomes were activated, making the analysis difficult. Nonetheless, under comparable control conditions to those described for the purified receptor, the open probability was 8%; and upon addition of CGA to the trans
compartment this increased to 52%. Altering the pH of the
trans compartment lowered the open probability to
~1%.
The addition of CGA to the trans compartment in the absence
of InsP3R had no effect upon the bilayer itself, and CGA
did not potentiate any InsP3R channel activity in the
absence of cytosolic InsP3. Furthermore, the addition of 1 µg of CGA to the cis compartment in the presence of
InsP3R and InsP3 did not affect channel activity.
As CGA is a highly charged protein, control experiments were carried
out to exclude the possibility that any charged macromolecule could be
responsible for the effects observed in this study. Heparin is one such
charged macromolecule and is known for its inhibitory effects on the
InsP3R when exposed to the cytosolic face of the receptor,
although it is not known to bind to its luminal face. The addition of 1 µg of heparin to the trans compartment (see Fig.
2b) did not alter channel open probability (5% for the
control compared with 4.4% in the presence of luminal heparin),
indicating that CGA does have a specific modulatory effect on
InsP3Rs.
Effect of CGA on InsP3 Dose Response for
InsP3R--
Single channel activity as a function of
InsP3 concentration, both in the presence and
absence of CGA, was characterized next (Fig.
4, a and b). Over a
range of InsP3 concentrations starting at 0.2 µM, the open probability was greater in the presence of CGA, with a 14-fold increase observed at 2 µM
InsP3. When the pH of the trans compartment was
changed to 7.5, the Po was reduced to that seen
in the control experiments. The results obtained from the single
channel experiments concur with those seen in the Ca2+
release studies (see Fig. 1) in that, at each InsP3
concentration and in the presence of CGA, a significant increase in
Po is concomitant to an increased amount of
released Ca2+.
Effect of CGA on Ca2+ Dependence for
InsP3R--
The Ca2+-dependence of the
InsP3R was investigated in the absence and presence of CGA
(Fig. 5, a and b)
at a fixed InsP3 concentration of 2 µM
and over a Ca2+ concentration range of 0.01-1.0
µM. As the Ca2+ concentration in the
cis compartment increased successively from 0.01 to 0.3 µM, the Po increased, reaching a
maximum value of 4% at 1 µM Ca2+
(pCa 6) in the absence of CGA (Fig. 5b). At
Ca2+ concentrations higher than 0.3 µM
(pCa 6.5), no inhibition was seen (see Fig. 5b,
expanded section). This lack of inhibition by free
Ca2+ has been observed previously for purified receptor
(28, 29) and contrasts to the inhibition seen with microsomes (30).
Repetition of this experiment, with the addition of CGA to the
trans compartment, produced dramatic increases in channel
activity (Fig. 5a). At a Ca2+ concentration of
0.01 µM (pCa 8) the Po
is effectively zero in the absence of CGA, in contrast to the
Po observed when CGA is present, which expressed
as a percentage of total open probability is 34%. Furthermore, the
Po effectively remains at this level irrespective despite increasing Ca2+ concentrations, and
again no inhibition by Ca2+ is seen. The activating phase
of the Ca2+ dependence seen in the absence of CGA is not
apparent in its presence. The channel has reached maximal open
probability at pCa 8. Thus, the lack of dependence on
Ca2+ for activation in the presence of CGA and 2 µM InsP3 is clearly illustrated.
Secretory granules of endocrine and neuroendocrine cells have been
shown to serve as InsP3-sensitive intracellular
Ca2+ stores (18, 31), and additional evidence from goblet
cells has demonstrated their direct participation in the control of cytoplasmic Ca2+ (20). Chromogranins are Ca2+
storage proteins that are found in secretory granules in millimolar concentrations (1-2 mM) (1, 32), and CGA binds 32 mol of Ca2+/mol with a dissociation constant of 2.7 mM
at pH 7.5 and 55 mol of Ca2+/mol with a dissociation
constant of 4 mM at pH 5.5 (33). Given the high capacity
Ca2+ binding of CGA, most of the 40 mM
intravesicular Ca2+ remains bound, thus yielding a total
free Ca2+ concentration of ~24 µM inside
the granules (34). As secretory granules occupy about 10% of the total
cell volume (at least in bovine chromaffin cells) (32) and have a high
storage capacity for Ca2+, they may play an important role
in governing intracellular Ca2+ dynamics.
This hypothesis is further supported by the discovery that
chromogranins A and B interact directly with type I InsP3Rs
located on the secretory granule membrane (24) and that this coupling is functional, at least in terms of CGA (25). The present results obtained from our bilayer studies reemphasize the functional importance of the interaction and provide the first mechanistic insight at the
level of a single InsP3R. The effects of CGA on
InsP3R channel activity, at the intravesicular pH of 5.5 (the pH at which the coupling occurs), are very profound. The increase
in both mean open time and open probability (Fig. 3) demonstrates
clearly that CGA causes the channel to open more frequently and, once
open, to stay open for longer times, which when translated to the
cellular level, implies a greater release of Ca2+. When the
intravesicular pH is altered to 7.5, the effects of CGA are seen to
dissipate almost instantly (Fig. 2, trace iii, and Fig. 3,
e and f) and resemble more closely those seen at
pH 5.5 in the absence of CGA. The InsP3 concentration
dependence both in bilayer studies and flux studies carried out at
comparable concentrations complement one another. At the single channel
level the InsP3R is seen to have a greater chance of
opening when CGA is present, and in the flux studies, the apparent
affinity for InsP3 is greater. Again, a change in pH to 7.5 causes the effect to revert to control levels. As for Ca2+
dependence, the InsP3R is already active at maximal levels
when CGA and InsP3 are present even when the level of
cytosolic free Ca2+ is only 10 nM (Fig. 5). The
data shown in Figs. 4 and 5 indicate that in the presence of coupled
CGA and a sufficient concentration of InsP3 (2 µM), the characteristic effects of cytosolic
Ca2+ on the InsP3R channel disappear. It
appears that the conformation of the InsP3R is in such a
state in the CGA-coupled condition, that high InsP3
dictates the channel activity regardless of the presence of
Ca2+.
How do these results relate to the physiological situation? In the
presence of CGA at intravesicular pH 5.5, the InsP3R is primed to respond to low levels of InsP3. Hence, when a
secretory granule reaches the surface of the cell and docks with the
inner surface of the plasma membrane, it is fully loaded with
Ca2+ and sensitized for release. Generation of
InsP3, even in small quantities, will cause a large
elevation in local Ca2+ concentration (values as high as
100 µM have been seen immediately prior to exocytosis)
(23), initiating secretory processes. During exocytosis, the vesicle
contents are exposed to the extracellular pH of 7.4, thus causing
dissociation of CGA from the InsP3R resulting in altered
channel properties and hence Ca2+ release. Following these
events, vesicular contents dissociate from the vesicle membrane,
with secretory cargo moving to the extracellular space and then into
the bloodstream.
The chromogranins, particularly CGA, appear to play a role in
intracellular Ca2+ dynamics and secretion, which also has
significant implications to human disease. For example, patients
suffering from pheochromocytoma and other neuroendocrine tumors have
significantly higher concentrations of CGA measured in the plasma (14,
15). This high plasma CGA indicates that high levels must have been
stored in order to be released. Individual cells contain increased CGA,
and there are more CGA-containing cells. In various cholestatic liver
diseases, a striking increase is seen in the number of bile ductules
(35). These reactive bile ductules differ from their normal
counterparts in that they display neuroendocrine features, in
particular the expression of CGA. Hence, the presence of elevated CGA
can lead to abnormal Ca2+ release within these cells, thus
activating specific metabolic mechanisms in the cell, which leads to
unnecessary growth. The increased release of neuroendocrine substances,
including CGA, may also play an autocrine or paracrine regulatory role
in ductular metaplasia of hepatocytes or bile ductule growth. Thus,
although the role of CGA in disease is largely attributed to
extracellular CGA and its derivatives, a contribution may arise also
from intragranular CGA with respect to its effects on
intracellular Ca2+ release and exocytosis.
In conclusion, our present work is the first electrophysiological study
detailing the very important physiological phenomenon arising from the
interaction between CGA, a Ca2+ storage protein, and an
intracellular Ca2+ release channel, InsP3R. We
have shown that there is an order of magnitude increase in the open
probability and open time of the InsP3-gated
Ca2+ channel. These effects of the interaction of CGA and
InsP3R have implications for exocytosis and neuroendocrine
cell function in disease.
*
This work was supported by Grant GM63496 from the National
Institutes of Health, an American Heart Association fellowship, Heritage Affiliate (to E. C. T.), and the Creative Research
Initiatives Program of the Ministry of Science and Technology, Korea.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Pharmacology,
Yale University, 333 Cedar St., New Haven, CT 06520-8066. Tel.:
203-737-1158; Fax: 203-785-7670; E-mail: edwin.thrower@yale.edu.
Published, JBC Papers in Press, February 12, 2002, DOI 10.1074/jbc.M110139200
The abbreviations used are:
CGA , chromogranin
A;
InsP3, inositol 1,4,5-trisphosphate;
InsP3R, InsP3R receptor;
PMSF, phenylmethylsulfonyl fluoride;
CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic
acid.
Activation of the Inositol 1,4,5-Trisphosphate Receptor by the
Calcium Storage Protein Chromogranin A*
§,
Departments of Pharmacology and
Cellular & Molecular Physiology, Yale University, New Haven,
Connecticut 06520 and ¶ National Creative Research Initiative
Center for Secretory Granule Research, Korea Advanced Institute
of Science and Technology, Dae Jeon 305-701, Korea
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-hydroxylase, t-plasminogen activator, and
binding secretory granule membrane constituents such as the
InsP3R (15).
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-mercaptoethanol, 0.1 mM PMSF, 10 µM leupeptin, 10 µM
pepstatin), homogenized, and centrifuged at 2000 × g
for 10 min at 4 °C. The supernatants were re-centrifuged at
105,000 × g for 1 h to precipitate the membrane
pellet, which was resuspended in buffer II (50 mM Tris-HCl,
pH 8.0, 1 mM EDTA, 1 mM
-mercaptoethanol,
0.1 mM PMSF, 10 µM leupeptin, 10 µM pepstatin) containing 1% Triton X-100, stirred for
1 h, and then centrifuged at 32,000 × g for
1 h at 4 °C. The resulting supernatant was mixed with an equal
volume of buffer III (20 mM Tris-HCl, pH 7.5, 0.1 M NaCl, 1% Triton X-100, 1 mM
-mercaptoethanol, 0.1 mM PMSF, 10 µM
leupeptin, 10 µM pepstatin), and applied to an
InsP3R antibody-coupled immunoaffinity column (0.35 × 1 cm) equilibrated with 20 mM HEPES, pH 7.5, 100 mM NaCl, 1 mM CaCl2. The
protein-loaded column was washed with 20 bed volumes of this buffer,
and the InsP3R was eluted by 10 ml of elution buffer (0.1 M glycine, pH 2.8, 0.2% Triton X-100, 0.5 M
NaCl, 1 mM
-mercaptoethanol, 0.1 mM PMSF, 10 µM leupeptin, 10 µM pepstatin). The eluate
was immediately neutralized by adding 1 M Tris-HCl, pH 9.5, and mixed with an equal volume of buffer IV (50 mM
Tris-HCl, pH 8.0, 0.2% Triton X-100, 0.5 M NaCl, 1 mM
-mercaptoethanol); it was then applied to a
benzamidine-Sepharose column equilibrated with Buffer V (20 mM HEPES, pH 7.5, 100 mM NaCl, 1 M
KCl, and 3 M urea). InsP3R containing
flow-through was collected and stored at
70 °C. until use.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (20K):
[in a new window]
Fig. 1.
Effects of CGA on InsP3-induced
Ca2+ release from InsP3R-reconstituted
liposomes. a, InsP3-induced
Ca2+ efflux through the proteoliposomes (300 µM Ca2+ inside) was determined by the
fluorescence change of indo-1 at 393 nm after a series of incremental
additions of InsP3 (4.0 µM final) to the
proteoliposome solution. The intraliposomal pH was pH 5.5 unless stated
otherwise. InsP3-induced Ca2+ release was also
measured in the presence of encapsulated CGA at intraliposomal pH of
5.5 and 7.5. b, the amount of released Ca2+
measured after a series of incremental additions of InsP3
(4.0 µM final) to the proteoliposome solution containing
1 µM indo-1 at 35 °C. InsP3-induced
fluorescent changes were compared with that obtained by the addition of
Triton X-100 (this value was set at 100%).

View larger version (29K):
[in a new window]
Fig. 2.
a, single channel activity in the
presence of InsP3R. Trace i, InsP3R
single channels activated by 2 µM InsP3
(added to the cis compartment). Openings are defined as
downward deflections from the base line. Trace
ii, conditions are same as for trace i, except
CGA (1 µg) was added to the trans compartment and mixed.
The pH of the trans compartment was pH 5.5. Trace
iii, The pH inside the trans compartment was changed by
the addition of Tris (final concentration 110 mM) to pH 7.5 (to dissociate CGA from IP3R). b, effect of
heparin, a charged macromolecule, on InsP3R function.
Top trace, InsP3R single channels activated by 2 µM InsP3 (added to the cis
compartment). Openings are defined as downward deflections from the
base line. Lower trace, heparin (1 µg) was added to the
trans compartment and mixed. The pH of the trans
compartment was pH 5.5. As CGA is a highly charged protein, these
control experiments exclude the possibility that any charged
macromolecule could be responsible for the effects observed in this
study.

View larger version (23K):
[in a new window]
Fig. 3.
Mean open times for InsP3R in the
presence and absence of CGA. a, mean open times for
InsP3R in the absence of CGA. Two populations of open times
are observed with values of 0.864 ± 0.039 and 8.84 ± 0.014 ms. b, an expanded section with a fit to the data. This
experiment is typical of four similar but separate experiments.
c, mean open times for InsP3R in the presence of
CGA. Again, two populations of open times are observed with values of
2.61 ± 0.024 and 103.5 ± 0.003 ms, but now the number of
longer openings has increased, and the mean open time is greater.
d, an expanded section with a fit to the data. The increase
in the number of longer open times is illustrated clearly. This
experiment is typical of four similar but separate experiments.
e, mean open times for InsP3R following
dissociation of CGA by pH change (pH 5.5 to pH 7.5). Two populations of
open times are observed with values of 1.05 ± 0.014 and 7.19 ± 0.013 ms, and the open times have returned to control levels.
f, an expanded section with a fit to the data
(n = 4).

View larger version (17K):
[in a new window]
Fig. 4.
Effect of CGA on InsP3 dose
response for InsP3R. Bilayer experiments were
repeated, same conditions as before, except over a range of
InsP3 concentrations. a,
InsP3 R single channels activated by 0.2-2
µM InsP3 (added to the cis
compartment) are shown. The InsP3 concentration used is
shown in the figure next to the relevant traces. Openings are defined
as downward deflections from the base line. The channel traces shown on
the left are in the absence of CGA. Channel traces shown on
the right are in the presence of CGA (1 µg) in the
trans compartment maintained at pH 5.5. b, at
each InsP3 concentration the open probability was measured
in the presence (
) and absence (
) of CGA. CGA significantly
enhances Po by at least 10-fold. The data set
shown is typical of four similar experiments.

View larger version (13K):
[in a new window]
Fig. 5.
Effect of CGA on Ca2+ dependence
for InsP3R. Bilayer experiments were repeated under
the same conditions as described under "Materials and
Methods" except over a range of cytosolic Ca2+
concentrations (0.01-10 µM). a,
InsP3R single channels activated by 2 µM
InsP3 and in the presence of different Ca2+
concentrations (added to the cis compartment) are shown. The
free Ca2+ concentration used is shown next to the relevant
traces. Openings are defined as downward deflections from the base
line. The channel traces shown on the left are in the
absence of CGA. Channel traces shown on the right are in the
presence of CGA (1 µg) in the trans compartment.
b, at each Ca2+ concentration the open
probability was measured in the presence (
) and absence (
) of
CGA. The Ca2+ dependence in the absence of CGA is shown
(expanded section is shown to emphasize that purified
InsP3Rs are not inhibited at higher cytosolic
Ca2+ concentrations). Again, CGA significantly enhances
Po. At the lowest Ca2+ concentration
the Po of the channel is already at 34%, with
no indication of an activation phase. The data set shown is typical of
four similar experiments.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Simon, J. P.,
and Aunis, D.
(1989)
Biochem. J.
262,
1-13[Medline]
[Order article via Infotrieve] 2.
Winkler, H.,
and Fischer-Colbrie, R.
(1992)
Neuroscience
49,
497-528[CrossRef][Medline]
[Order article via Infotrieve] 3.
Helle, K. B.
(1966)
Mol. Pharmacol.
2,
298-310 4.
Blaschko, H.,
Comline, R. S.,
Schneider, F. H.,
Silver, M.,
and Smith, A. D.
(1967)
Nature
215,
58-59[CrossRef][Medline]
[Order article via Infotrieve] 5.
Smith, A. D.,
and Winkler, H.
(1967)
Biochem. J.
103,
483-492[Medline]
[Order article via Infotrieve] 6.
Tatemoto, K.,
Efendic, S.,
Mutt, V.,
Makk, G.,
Feistner, G. J.,
and Barchas, J. D.
(1986)
Nature
324,
476-478[CrossRef][Medline]
[Order article via Infotrieve] 7.
Lewis, J. J.,
Zdon, M. J.,
Adrian, T. E.,
and Modlin, I. M.
(1988)
Surgery
104,
1031-1036[Medline]
[Order article via Infotrieve] 8.
Drees, B. M.,
Rouse, J.,
Johnson, J.,
and Hamilton, J. W.
(1991)
Endocrinology
129,
3381-3387[Abstract] 9.
Aardal, S.,
Helle, K. B.,
Elsayed, S.,
Reed, R. K.,
and Serck-Hanssen, G.
(1993)
J. Neuroendocrinol.
5,
405-412[CrossRef][Medline]
[Order article via Infotrieve] 10.
Helle, K. B.,
Serck-Hanssen, G.,
and Aardal, S.
(1993)
Neurochem. Int.
22,
353-360[CrossRef][Medline]
[Order article via Infotrieve] 11.
Fasciotto, B. H.,
Trauss, C. A.,
Greeley, G. H.,
and Cohn, D. V.
(1993)
Endocrinology
133,
461-466[Abstract] 12.
Mahata, S. K.,
O'Connor, D. T.,
Mahata, M.,
Yoo, S. H.,
Taupenot, L., Wu, H.,
Gill, B. M.,
and Parmer, R. J.
(1997)
J. Clin. Invest.
100,
1623-1633[Medline]
[Order article via Infotrieve] 13.
Strub, J. M.,
Sorokine, O.,
Van Dorsselaer, A.,
Aunis, D.,
and Metz-Boutigue, M. H.
(1997)
J. Biol. Chem.
272,
11928-11936 14.
Aardal, S.,
Aardal, N. P.,
Larsen, T. H.,
Angeletti, R. H.,
Stridsberg, M.,
Taupenot, L.,
Aunis, D.,
and Helle, K. B.
(1996)
Scand. J. Clin Lab. Invest.
56,
511-523[Medline]
[Order article via Infotrieve] 15.
Helle, K. B.,
and Aunis, D.
(2000)
Adv. Exp. Med. Biol.
482,
389-397[Medline]
[Order article via Infotrieve] 16.
Kopell, W. N.,
and Westhead, E. W.
(1982)
J. Biol. Chem.
257,
5707-5710 17.
Daniels, A. J.,
Williams, R. J.,
and Wright, P. E.
(1978)
Neuroscience
3,
573-585[CrossRef][Medline]
[Order article via Infotrieve] 18.
Yoo, S. H.,
and Albanesi, J. P.
(1990)
J. Biol. Chem.
265,
13446-13448 19.
Gerasimenko, O. V.,
Gerasimenko, J. V.,
Belan, P. V.,
and Petersen, O. H.
(1996)
Cell
84,
473-480[CrossRef][Medline]
[Order article via Infotrieve] 20.
Nguyen, T.,
Chin, W. C.,
and Verdugo, P.
(1998)
Nature
395,
908-912[CrossRef][Medline]
[Order article via Infotrieve] 21.
Yoo, S. H.,
and Lewis, M. S.
(1992)
J. Biol. Chem.
267,
11236-11241 22.
Thiele, C.,
and Huttner, W. B.
(1998)
J. Biol. Chem.
273,
1223-1231 23.
Yoo, S. H.
(2000)
Trends Neurosci.
23,
424-428[CrossRef][Medline]
[Order article via Infotrieve] 24.
Yoo, S. H., So, S. H.,
Kweon, H. S.,
Lee, J. S.,
Kang, M. K.,
and Jeon, C. J.
(2000)
J. Biol. Chem.
275,
12553-12559 25.
Yoo, S. H.,
and Jeon, C. J.
(2000)
J. Biol. Chem.
275,
15067-15073 26.
Thrower, E. C.,
Mobasheri, H.,
Dargan, S.,
Marius, P.,
Lea, E. J.,
and Dawson, A. P.
(2000)
J. Biol. Chem.
275,
36049-36055 27.
Tsien, R.,
and Pozzan, T.
(1989)
Methods Enzymol.
172,
230-262[Medline]
[Order article via Infotrieve] 28.
Thrower, E.,
Lea, E.,
and Dawson, A.
(1998)
Biochem. J.
330,
559-564 29.
Michikawa, T.,
Hirota, J.,
Kawano, S.,
Hiraoka, M.,
Yamada, M.,
Furuichi, T.,
and Mikoshiba, K.
(1999)
Neuron
23,
799-808[CrossRef][Medline]
[Order article via Infotrieve] 30.
Bezprozvanny, I.,
Watras, J.,
and Ehrlich, B. E.
(1991)
Nature
351,
751-754[CrossRef][Medline]
[Order article via Infotrieve] 31.
Blondel, O.,
Bell, G. I.,
and Seino, S.
(1995)
Trends Neurosci.
18,
157-161[CrossRef][Medline]
[Order article via Infotrieve] 32.
Winkler, H.,
and Westhead, E.
(1980)
Neuroscience
5,
1803-1823[CrossRef][Medline]
[Order article via Infotrieve] 33.
Yoo, S. H.,
and Albanesi, J. P.
(1991)
J. Biol. Chem.
266,
7740-7745 34.
Bulenda, D.,
and Gratzl, M.
(1985)
Biochemistry
24,
7760-7765[CrossRef][Medline]
[Order article via Infotrieve] 35.
Roskams, T.,
van den Oord, J. J., De,
Vos, R.,
and Desmet, V. J.
(1990)
Am. J. Pathol.
137,
1019-1025[Abstract]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. E. Wagner II, S. K. Joseph, and D. I. Yule Regulation of single inositol 1,4,5-trisphosphate receptor channel activity by protein kinase A phosphorylation J. Physiol., August 1, 2008; 586(15): 3577 - 3596. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Foskett, C. White, K.-H. Cheung, and D.-O. D. Mak Inositol Trisphosphate Receptor Ca2+ Release Channels Physiol Rev, April 1, 2007; 87(2): 593 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-u. Choe and B. E. Ehrlich The Inositol 1,4,5-Trisphosphate Receptor (IP3R) and Its Regulators: Sometimes Good and Sometimes Bad Teamwork Sci. Signal., November 28, 2006; 2006(363): re15 - re15. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Thrower, A. P. E. Diaz de Villalvilla, T. R. Kolodecik, and F. S. Gorelick Zymogen activation in a reconstituted pancreatic acinar cell system Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G894 - G902. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Jacob, C.-U. Choe, P. Uhlen, B. DeGray, M. F. Yeckel, and B. E. Ehrlich Signaling Microdomains Regulate Inositol 1,4,5-Trisphosphate-Mediated Intracellular Calcium Transients in Cultured Neurons J. Neurosci., March 16, 2005; 25(11): 2853 - 2864. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-U. Choe, K. D. Harrison, W. Grant, and B. E. Ehrlich Functional Coupling of Chromogranin with the Inositol 1,4,5-Trisphosphate Receptor Shapes Calcium Signaling J. Biol. Chem., August 20, 2004; 279(34): 35551 - 35556. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cai, C. Hisatsune, K. Nakamura, T. Nakamura, T. Inoue, and K. Mikoshiba Activity-dependent Expression of Inositol 1,4,5-Trisphosphate Receptor Type 1 in Hippocampal Neurons J. Biol. Chem., May 28, 2004; 279(22): 23691 - 23698. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Thrower, C. U. Choe, S. H. So, S. H. Jeon, B. E. Ehrlich, and S. H. Yoo A Functional Interaction between Chromogranin B and the Inositol 1,4,5-Trisphosphate Receptor/Ca2+ Channel J. Biol. Chem., December 12, 2003; 278(50): 49699 - 49706. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Caroppo, M. Colella, A. Colasuonno, A. DeLuisi, L. Debellis, S. Curci, and A. M. Hofer A Reassessment of the Effects of Luminal [Ca2+] on Inositol 1,4,5-Trisphosphate-induced Ca2+ Release from Internal Stores J. Biol. Chem., October 10, 2003; 278(41): 39503 - 39508. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ando, A. Mizutani, T. Matsu-ura, and K. Mikoshiba IRBIT, a Novel Inositol 1,4,5-Trisphosphate (IP3) Receptor-binding Protein, Is Released from the IP3 Receptor upon IP3 Binding to the Receptor J. Biol. Chem., March 14, 2003; 278(12): 10602 - 10612. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. Johenning, M. Zochowski, S. J. Conway, A. B. Holmes, P. Koulen, and B. E. Ehrlich Distinct Intracellular Calcium Transients in Neurites and Somata Integrate Neuronal Signals J. Neurosci., July 1, 2002; 22(13): 5344 - 5353. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||